FDA Approves J&J, Glaxo HIV Drug, Roche Presents Data

Pipeline and regulatory updates were the focus this week with the FDA approving the first two-drug HIV treatment in the United States and the European Commission granting approval to Johnson & Johnson’s Tremfya.